Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment.
Anderson TS, Ayanian JZ, Souza J, Landon BE..
. Free PMC article.
.
.
. Kim YJ, et al.Alzheimers Dement (N Y). 2021 May 13;7(1):e12174. doi: 10.1002/trc2.12174. eCollection 2021.Alzheimers Dement (N Y). 2021.PMID: 34027024.
.
.
Diversity of developing peripheral glia revealed by single-cell RNA sequencing.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
